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Abstract
Campylobacter jejuni is a major zoonotic pathogen, and its resistance to antibiotics is of great concern for
public health. However, few studies have investigated the global changes of the entire organism with respect to
antibiotic resistance. Here, we provide mechanistic insights into high-level resistance to chloramphenicol in C.
jejuni, using integrated genomic and proteomic analyses. We identified 27 single nucleotide polymorphisms
(SNPs) as well as an efflux pump cmeBmutation that conferred modest resistance. We determined two radical
S-adenosylmethionine (SAM) enzymes, one each from an SNP gene and a differentially expressed protein.
Validation of major metabolic pathways demonstrated alterations in oxidative phosphorylation and ABC
transporters, suggesting energy accumulation and increase in methionine import. Collectively, our data
revealed a novel rRNA methylation mechanism by a radical SAM superfamily enzyme, indicating that two
resistance mechanisms existed in Campylobacter. This work provided a systems biology perspective on
understanding the antibiotic resistance mechanisms in bacteria.
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Integrated Genomic and 
Proteomic Analyses of High-level 
Chloramphenicol Resistance in 
Campylobacter jejuni
Hui Li1,2, Yingyu Wang1, Qin Fu1, Yang Wang1, Xiaowei Li1, Congming Wu1, Zhangqi Shen1, 
Qijing Zhang3, Peibin Qin4, Jianzhong Shen1 & Xi Xia1
Campylobacter jejuni is a major zoonotic pathogen, and its resistance to antibiotics is of great concern 
for public health. However, few studies have investigated the global changes of the entire organism 
with respect to antibiotic resistance. Here, we provide mechanistic insights into high-level resistance to 
chloramphenicol in C. jejuni, using integrated genomic and proteomic analyses. We identified 27 single 
nucleotide polymorphisms (SNPs) as well as an efflux pump cmeB mutation that conferred modest 
resistance. We determined two radical S-adenosylmethionine (SAM) enzymes, one each from an SNP 
gene and a differentially expressed protein. Validation of major metabolic pathways demonstrated 
alterations in oxidative phosphorylation and ABC transporters, suggesting energy accumulation and 
increase in methionine import. Collectively, our data revealed a novel rRNA methylation mechanism 
by a radical SAM superfamily enzyme, indicating that two resistance mechanisms existed in 
Campylobacter. This work provided a systems biology perspective on understanding the antibiotic 
resistance mechanisms in bacteria.
Campylobacter jejuni is a major zoonotic pathogen and the leading bacterial cause of food-borne gastroenteri-
tis worldwide1,2. Although most C. jejuni infections are clinically mild and self-limiting, the bacterium may 
cause severe infections in immunocompromised patients as well as serious post-infection complications such as 
Guillain-Barre syndrome and Miller-Fisher syndrome3,4. Therapeutic intervention is imperative in patients with 
severe or long-lasting infections, or with compromised immune systems5. However, the antimicrobial resistance 
of C. jejuni has increased significantly over the past decades and has become a major threat to public health6,7.
The use of antibiotics for growth promotion in livestock is of particular concern, because low doses of anti-
biotics when applied over long periods can create a breeding ground for the emergence of resistant bacteria. 
Apart from its use in both human and veterinary practice to treat infections, chloramphenicol (CAP) was once 
a widely used feed additive for food-producing animals, owing to its low cost and effectiveness against a wide 
variety of gram-positive and gram-negative bacteria. Nowadays, the use of CAP is limited to a small number of 
life-threatening infections in humans and is banned in many countries in animal husbandry because of its adverse 
effects8,9. Nevertheless, the detection rate of CAP-resistant Campylobacter is still high in some countries10,11. CAP 
binds directly to the 50 S ribosomal subunit and inhibits peptide bond formation by interacting with the peptidyl 
transferase center12. Previously reported bacterial resistance mechanisms to CAP included drug acetylation13, 
efflux pumps14–17, and methylation of rRNA by cfr18.
In our previous work, a point mutation, G2073A, was identified in 23 S rRNA in CAP-selected mutants of C. 
jejuni19. However, further study was needed to investigate whether this point mutation alone was sufficient to 
confer high-level resistance to CAP in the C. jejuni mutants. Here, we aimed to characterise the global changes 
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in CAP-resistant mutants of C. jejuni, using integrated genomic sequencing and quantitative proteomic analysis. 
This work defined a previously unrecognized mechanism underlying high-level resistance to CAP in C. jejuni, 
demonstrating the usefulness of the systems biology approach in elucidating drug resistance mechanisms.
Results
Involvement of multiple mutations in CAP resistance. The CAP-resistant C4 strain and the parental 
strain C. jejuni ATCC 33560 were completely sequenced (GenBank accession number, CP019838), and both 
strains contained a single contig of 1.78 Mbp with no plasmids (Fig. 1a,b). Genomic annotation of the parental 
strain indicated the presence of 1,869 putative coding sequences (Table S1). A co-linearity analysis revealed that 
C. jejuni ATCC 33560 had similar genome characteristics to those of C. jejuni NCTC 11168 (Fig. 1c). No known 
antibiotic resistance genes were identified in the resistant strain. Twenty-seven single nucleotide polymorphisms 
(SNPs) were identified between the mutant and parental strains (18 nonsynonymous, 1 stop-gain, 1 synonymous, 
and 7 noncoding; Fig. 1d and Table 1), among which cje1821 exhibited three nonsynonymous substitutions. The 
two substitutions (G2073A and G74D) we found in our previous report were also identified here (Table 1)19. To 
investigate the role of these SNPs in the resistance mechanism, we constructed gene-knockout mutant strains 
of the 17 genes with nonsynonymous and stop-gain SNPs. Five genes (cje0220, cje0275, cje1167, cje1432, and 
cje1821) were successfully knocked out in resistant C4 strains. Then the resistance phenotype of these five knock-
out strains (Δcje0220, Δcje0275, Δcje1167, Δcje1432, and Δcje1821) was determined. Antibiotic susceptibility 
tests showed that the minimum inhibition concentrations (MICs) of CAP remained at 256 μg/mL for Δcje0220 
and Δcje1167, whereas for Δcje0275, Δcje1432, and Δcje1821, the MIC was decreased to 64 μg/mL. These find-
ings indicated that the high-level resistance to CAP in C. jejuni was mediated by multiple gene alterations.
To further confirm the role of each SNP mutant gene to the resistance phenotype, two putative resistant genes 
(cje1167 and cje1432) were successfully inserted into the wild-type strain C. jejuni NCTC11168 using single gene 
insertion method. The cje1167 and cje1432 mutant genes were not successfully reintroduced into the wild type 
strain C. jejuni ATCC 33560. It was might due to the characteristics of this strain and was not easy to integrate 
other genes to its genome. Compared with C. jejuni NCTC 11168 wild type strains, a 4-fold increase in the MIC 
of CAP (from 2 μg/mL to 8 μg/mL) was observed for the constructed C. jejuni NCTC11168 + cje1432 and C. 
jejuni NCTC11168 + cje1167. The contribution of cje1432 and cje1167 gene in the CAP resistance of C. jejuni 
was confirmed.
Figure 1. Complete genomes and comparative genomic analysis of parental strain and CAP-resistant strain. 
Circular representation of chromosome from C. jejuni ATCC 33560 (a) and CAP-resistant strain (b). Circles 
(from the center toward periphery) indicate the following: first, GC skew; second, G + C content; third, ORFs 
predicted on the minus strand; fourth, putative gene, rRNA and tRNA in the minus strand; fifth, putative gene, 
rRNA and tRNA in the sense strand; sixth, COG annotations of genes in the sense strand. (c) Co-linear analysis 
of genome between C. jejuni ATCC 33560 and C. jejuni NCTC 11168 using MUMmer. The green connecting 
bars indicated high sequence identity and the red bars a reverse orientation. (d) Number of mutant loci and 
categories of mutations in CAP-resistant strain.
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Accumulation of CAP in resistant C. jejuni. To evaluate the role of efflux pumps in CAP-resistant C. 
jejuni, an ultra-high performance liquid chromatography-tandem quadrupole mass spectrometry method 
was developed to determine the concentration of CAP in the bacteria. If efflux pumps alone could mediate the 
resistance, we would either not detect CAP in C. jejuni or the concentration of CAP would be controlled under 
a certain threshold regardless of how high the drug pressure was in the culture medium. In this experiment, 
CAP-resistant C4 strains (MIC = 256 μg/mL) were cultured on Muller-Hinton agar plates supplemented with 
CAP at 4, 16, or 32 μg/mL. The harvested bacteria were successively rinsed with water and methanol before 
extraction to ensure that the residual CAP outside the bacteria was removed. The rinsed methanol fraction was 
also analysed, and no CAP was detected under the analytical conditions. As shown in Fig. S1, the concentrations 
of CAP extracted from the bacteria were 15.4, 31.4, and 37.8 pg/mg, increasing correspondingly with the drug 
concentrations in the culture medium. This result indicated that CAP was not completely extruded out of cells by 
efflux pumps, and that there were other factors contributing to the high-level resistance.
Alterations in the proteome of CAP-resistant mutants. The proteomes of resistant strain and the 
parental strain were profiled to better understand the resistance mechanism. Using a label-free quantitative pro-
teomics approach based on sequential window acquisition of all theoretical fragment-ion spectra mass spec-
trometry (SWATH-MS), we identified 1,295 proteins with a false discovery rate of <1% and quantified 1,151 
proteins (Table S2). In total, 227 differentially expressed proteins (DEPs) were identified in the resistant and 
parental strains, including 132 up-regulated and 95 down-regulated proteins (Table S3). The DEPs were classified 
into three major functional ontologies (cellular component, molecular function, and biological process), using 
Gene Ontology (GO) enrichment analyses (Fig. 2a–f). Among the DEPs, four proteins (two up-regulated and 
two down-regulated) are the original products of the genes with SNPs. The concentration of the protein encoded 
by cje0766 decreased dramatically, by nearly 20-fold, as expected, because a stop-gain mutation was identified in 
cje0766. Another down-regulated protein was that encoded by cje0275, resulting in partial recovery of antimicro-
bial susceptibility upon knock out. The two up-regulated proteins were cje1516 (RNA polymerase sigma factor 
FliA) and cje1167, which belongs to the radical SAM superfamily. To further investigate the interaction of DEPs, 
up-regulated (Fig. S2A) and down-regulated (Fig. S2B) DEP networks were generated using STRING 10.0 and 
Cytoscape 3.4.0. Using the Kyoto Encyclopedia of Genes and Genomes (KEGG) metabolic pathway analysis, the 
DEPs involved in major pathways were identified. The major pathways enriched by the up-regulated proteins were 
oxidative phosphorylation, two-component system, and ABC transporters, and for down-regulated proteins, the 
major pathways were ABC transporters, biosynthesis of amino acids, ribosome, and two-component system.
Reference Alteration Gene Function Putative protein/RNA Mutation type Amino acid change
G A cje0035, cje0036 intergenic
T C cje0036 downstream
G A cje0075 CDS transcription termination/antitermination protein NusG nonsynonymous c.G433A:p.E145K
G A cje0220 CDS NOL1/NOP2/sun family protein nonsynonymous c.G331A:p.G111S
G A cje0275 CDS peptidyl-prolyl cis-trans isomerase nonsynonymous c.G1483A:p.G495R
G A cje0289 CDS putative ribosomal pseudouridine synthase nonsynonymous c.G494A:p.S165N
G A cje0332,cje0333 intergenic
T C cje0333 upstream
A G cje0473, cje0474, cje0475 upstream, downstream
G T cje0766 CDS NAD(P)H-dependent oxidoreductase stopgain c.G160T:p.E54X
C T cje0886 CDS 30 S ribosomal protein S2 nonsynonymous c.G118A:p.D40N
C T cje1065 CDS hypothetical protein synonymous c.G423A:p.E141E
C T cje1119 CDS putative cytochrome P450 nonsynonymous c.G221A:p.S74N
C T cje1167 CDS radical SAM protein nonsynonymous c.G113A:p.R38K
C T cje1427 CDS 50 S ribosomal protein L4 nonsynonymous c.G221A:p.G74D
C T cje1432 CDS 16 S rRNA dimethyltransferase nonsynonymous c.G769A:p.D257N
G A cje1486, cje1487 intergenic 23 s rRNA . c.G2073A
G A cje1496 CDS GTP-binding protein TypA nonsynonymous c.C1561T:p.L521F
A - cje1516 CDS RNA polymerase sigma factor FliA nonsynonymous
G A cje1554, cje1555 upstream, downstream . .
G A cje1562 CDS ATP synthase subunit alpha nonsynonymous c.G1237A:p.G413R
C T cje1650 CDS amidophosphoribosyltransferase nonsynonymous c.G268A:p.A90T
A G cje1728 CDS rod shape-determining protein MreB nonsynonymous c.A115G:p.I39V
C T cje1811 CDS DNA-binding response regulator nonsynonymous c.G403A:p.E135K
C T cje1821 CDS CmeB nonsynonymous c.G2003A:p.G668E
G A cje1821 CDS CmeB nonsynonymous c.C1871T:p.A624V
G A cje1821 CDS CmeB nonsynonymous c.C425T:p.S142F
Table 1. SNPs in CAP-resistant strain.
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Validation of SNPs and SWATH results using selected reaction monitoring assays. Considering 
that only four SNPs matched the DEPs, and approximately 12% of proteins of the proteome were differentially 
expressed, we applied a selected reaction monitoring (SRM) MS approach to confirm the protein expression of 
the genes with SNPs and DEPs. Fifteen DEPs from SWATH were selected for further validation in two KEGG 
pathways, namely, oxidative phosphorylation (six up-regulated) and ABC transporters (two up-regulated and 
seven down-regulated), owing to their close correlativity or possible association with drug resistance. In addition, 
all the original proteins of the 18 genes with substitutions in coding regions were selected for SRM validation. 
Next, to develop and optimise a specific SRM method for each protein, a set of peptides were selected from a col-
lection of the shotgun proteomic analysis of C. jejuni. For each peptide, we tested different predicted SRM transi-
tions and extracted up to five peptides and six transitions per peptide that resulted in the highest signals for each 
protein, together with peptide elution times. Finally, we successfully generated a multiplexed, time-scheduled 
SRM assay using 596 transitions for 33 selected proteins (Table S4).
We exploited the multiplexed SRM assay to measure the selected proteins from resistant strain and the paren-
tal strain. The proteins were quantified by calculating the average of multiple SRM transition intensities per pep-
tide and multiple peptides per protein. As shown in Fig. 3, the SRM and SWATH analyses exhibited similar trends 
for all selected proteins, except cje0289, which could not be identified by SWATH profiling. The developed SRM 
method detected this protein and found that it was down-regulated in resistant strains.
Influence of CAP resistance on bacterial metabolic pathways. SRM assays validated the SWATH 
profiling results and therefore confirmed specific metabolic pathways associated with resistance (Fig. 4). Both 
SWATH and SRM showed that cje1283, cje1284, cje1286, cje1287, cje1288, and cje1289 were up-regulated, with 
approximately two-fold increase, in resistant strains. These six proteins correspond to NADH-quinone oxidore-
ductase subunits A, B, C, D, F, and G, all of which belong to NADH dehydrogenase in the oxidative phosphoryla-
tion process. Cje0767, like cje0766, was also down-regulated by 20-fold in resistant strains, and corresponded to 
an NAD(P)H-dependent oxidoreductase that was not included in the KEGG pathway. These results revealed that 
resistant strains inactivated an unknown metabolic pathway and then relied more on NADH dehydrogenase in 
the oxidative phosphorylation pathway. Subsequently, we identified two additional proteins (and the correspond-
ing genes) involved in the oxidative phosphorylation pathway that were subunits of ATP synthase. Cje1562 (ATP 
synthase subunit alpha) exhibited a G1237A substitution but the protein expression was not changed, whereas 
the expression of cje1563 (ATP synthase subunit gamma) was increased by >two-fold. Although the specific 
Figure 2. Gene ontology enrichment analysis of up-regulated and down-regulated DEPs. GO terms of up-
regulated and down-regulated DEPs were categorized into biological process (a,d), molecular function (b,e), 
and cellular component (c,f) using Blast2GO software.
www.nature.com/scientificreports/
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functions and interactions of these proteins in C. jejuni were not very clear, collectively these findings demon-
strated that the energy metabolism was adjusted in resistant strains to overcome the drug pressure.
The ABC transporters were also fully validated using SRM, including the up-regulated cje0357 (MetN) and 
cje0981 (FtsE) and the down-regulated cje1758 (ModA), cje1634 (AfuA), cje0199 (PstS), cje1059 (FhuD), cje1335 
(FhuD), cje1603 (ZnuA), and cje1602 (ZnuC). These DEPs participated in the transport of mineral and organic 
ions, metallic cations, phosphates, and amino acids. In the resistant strains, the intake of molybdate, iron ion and 
iron complex, zinc, and phosphate was suppressed, whereas the import of d-methionine was increased.
Discussion
Different resistance genes have been reported as conferring resistance to CAP, but few strains have been identified 
containing multiple CAP resistance genes. Little is known about the correlation between these various resistance 
genes or whether they act synergistically to confer resistance, and few studies have been conducted to investigate 
the responses of the whole organism to resistance, because current studies still focus only on genetic changes. In 
the present study, the molecular basis of CAP resistance in C. jejuni was characterised using integrated genomics 
and quantitative proteomics approaches. We discovered new resistance mutation and observed their combined 
Figure 3. Quantification results from SWATH and SRM analyses.
Figure 4. Schematic representation of disturbed metabolic pathways in CAP-resistant strains including ABC 
transporter, oxidative phosphorylation, ribosomal assembly, and two-component system. Disturbed metabolic 
pathway were indicated in RED.
www.nature.com/scientificreports/
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contributions to bacterial resistance. In addition, we identified that the shifts of several metabolic pathways were 
essential to resistance in C. jejuni.
To unravel the role of SNPs in the resistance mechanism of C. jejuni, we constructed gene-knockout mutants 
of each gene individually, and then evaluated their phenotype of CAP resistance. We found that at least three 
mutant genes contributed jointly to confer high-level CAP resistance in C. jejuni. Three nonsynonymous sub-
stitutions were identified in the efflux transporter gene cmeB (cje1821), and knockout of this gene resulted in 
only partial recovery of drug susceptibility. Overexpression of these efflux transporters is typically required 
for mediating antibiotic resistance20,21, and it has recently been shown that both the sequence variation and 
enhanced expression of cmeABC contributed to enhancing the resistance to multiple antibiotics, including CAP, 
in Campylobacter22. In this study, the SWATH proteomics data showed that cmeB expression was not changed in 
resistant strains, which was then validated by SRM assays, but the variant cmeB only conferred a modest level of 
resistance to CAP. The accumulation of CAP in resistant strains proved the existence of resistance mechanisms 
other than the efflux pump. Cje1432, another SNP affecting the MIC of CAP, encodes a dimethyltransferase that 
catalyses the transfer of methyl groups from S-adenosylmethionine (SAM) to two adjacent adenosines (A1518 
and A1519) in the loop of a conserved hairpin near the 3′-end of 16 S rRNA23, and its mutations led to resistance 
against the aminoglycoside antibiotic kasugamycin in Neisseria gonorrhoeae24. The specific function of cje1167 
has been verified in the constructed C. jejuni NCTC 11168 + cje1167 mutant strains using single gene inser-
tion method. This evidence suggests that mutation of the 16 S rRNA dimethyltransferase confers resistance to 
CAP in Campylobacter. The product of the third successful knockout SNP (cje0275) is peptidyl-prolyl cis-trans 
isomerase, a SurA-like protein. SurA is the primary chaperone that facilitates membrane insertion of most outer 
membrane proteins in gram-negative bacteria25. Deletion of surA in Escherichia coli causes a decrease in outer 
membrane density and an increase in bacterial drug susceptibility, which means that the decrease of MICs in 
gene-knockout phenotype strains may be due to the deletion of the gene rather than the SNP. However, SWATH 
and SRM analyses both showed a two-fold decrease of protein expression of cje0275 in resistant strains. The 
mutant sequence in the protein of cje0275 may play a role in the resistance mechanism.
Cje1167 was screened out by comparative genomics, SWATH profiling, and SRM validation, showing G113A 
substitution in its coding sequence and up-regulated protein levels in resistant strains. Radical SAM enzymes 
utilise potent radical intermediates to perform an array of unusual and chemically difficult transformations, 
including methylation, isomerization, sulphur insertion, ring formation, anaerobic oxidation, and protein radical 
formation26. cfr is a well-known resistance gene belonging to the SAM superfamily27,28. It encodes 23 S rRNA 
methyltransferase and confers resistance to multiple drugs, including CAP, in bacteria. Our data suggest that, 
similar to cfr, the cje1167 variant could also be responsible for the resistance to CAP in Campylobacter.
After evaluating the adjusted metabolic pathways in resistant strains, and linking them to the SNPs and related 
proteins, we believe that a radical SAM enzyme–mediated mechanism exists in resistant C. jejuni. First, we found 
that resistant strains promote energy accumulation for the radical enzyme reaction. Oxidative phosphorylation 
serves as the major route for energy metabolism in Campylobacter. Resistant strains disable an unknown meta-
bolic pathway regulated by cje0766 and cje0767 and switch to NADH dehydrogenase complex I in the oxidative 
phosphorylation pathway. NADH dehydrogenase and ATP synthase were both up-regulated by two-fold. Second, 
the import of methionine was increased by overexpression of the ABC transporter MetN. Methionine is the 
immediate precursor of SAM, which is one of the major methyl-group donors in trans-methylation reactions29. 
Third, two potential radical SAM enzymes were found to be associated with the SNP genes. Cje1432 encodes a 
dimethyltransferase, catalysing the methylation of 16 S rRNA through SAM, and cje1167 belongs to a radical 
SAM superfamily. Given these findings, we propose that the radical SAM enzyme confers CAP resistance by 
methylation of rRNA, thereby providing protection from drug binding.
Western blotting used to be the gold standard for validating proteins obtained using discovery proteomics 
in complex samples as an orthogonal method, but it is usually restricted to the availability of antibodies when 
performing large-scale validation. Nowadays, SRM assays based on targeted MS have replaced western blotting 
for protein quantification across samples owing to its accuracy, reproducibility, and sensitivity30. In this study, 
although the fold changes varied to some degree, the change tendencies of proteins from SRM assays were con-
sistent with those from SWATH profiling. In particular, we not only identified mutant peptides from two SNP 
genes (cje0075 and cje1811), using SRM, which were not identified by SWATH, but also determined an SNP gene 
(cje0289) that was not detected by SWATH and even found its lower expression in resistant strains. Cje0075 is the 
transcription termination/antitermination protein NusG, an ubiquitous transcription elongation factor conserver 
in bacteria31, and cje1811 is a DNA-binding response regulator belonging to the OmpR family32. Although these 
three SNP proteins are involved in RNA synthesis and signal transduction, their precise role(s) in CAP resistance 
remains to be ascertained.
In summary, we devised a strategy in which comparative genomics and quantitative proteomics were com-
bined to assemble a comprehensive picture of CAP resistance in C. jejuni. Our findings suggest that multi-
ple genes, particularly those encoding mutant cmeB and a radical SAM enzyme, contribute jointly to confer 
high-level resistance to CAP. Furthermore, major metabolic pathways were identified, revealing their adjustment 
and impact on the resistance mechanism. However, the functions of SNPs with uncertain roles as well as those of 
many DEPs should be verified in future studies. Our strategy represents a significant step towards characterizing 
genome- and proteome-wide alterations in antibiotic-resistant bacteria, and thus opens the way to elucidate the 
drug resistance mechanism from a systems biology perspective.
Methods
Eliciting antibiotic resistance and culture conditions. To generate antibiotic-resistant mutants, the 
C. jejuni ATCC 33560 parental strain was inoculated onto multiple Muller-Hinton (MH) agar plates (Fluka, 
Sigma-Aldrich, St. Louis, MO), and then independent stepwise in vitro selection experiments were conducted for 
www.nature.com/scientificreports/
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resistance to CAP. Single colonies (n = 10) were picked and tested at each stepwise selection. The bacteria were 
grown on MH agar plates at 42 °C under microaerobic conditions (5% O2, 5% CO2, and 90% N2). Antimicrobial 
susceptibility testing was conducted using the standard agar dilution method according to the guidelines of 
the Clinical and Laboratory Standards Institute33. C. jejuni ATCC 33560 was used as the quality control stain. 
Experiments were repeated at least three times. A high-level resistant strain C4 from a single colony was selected 
in the further study.
DNA extraction, whole genome sequencing, and assembly. DNA from the CAP-resistant and 
parental strains was isolated using the Wizard® Genomic DNA Purification Kit (Promega, Madison, WI, US). 
Library preparation was carried out as a 10-kb insert library using C2 chemistry and sequenced using the single 
molecular real-time sequencing (SMRT) technique by PacBio RS system (Pacific Biosciences, Menlo Park, CA), 
yielding >50× average genome coverage. De novo assembly of the reads was carried out using continuous long 
reads following the Hierarchical Genome Assembly Process workflow (PacBio DevNet; Pacific Biosciences) as 
available in SMRT Analysis v2.0. The assembled genome was annotated using the NR/NT, Swiss-Prot, COG, 
GO, and KEGG databases. The SNPs identified in resistant mutants were compared to those of the parental 
strain, using Mauve 2.3.134 and MUMmer35. Putative mutations identified were filtered to remove those with a 
Phred-scaled quality score of <100.
Gene-knockout and gene-knockin mutant strains construction. Knockout strains of SNP mutant 
loci were constructed as described previously36. Briefly, primers for mutant construction were designed based on 
the genome sequence of the resistant strain. The primers used for knockout mutant construction were shown in 
Table S5. The DNA fragments (upstream and downstream homologous arms) of the mutant gene were amplified 
using a high-fidelity DNA polymerase. The kanamycin resistance cassette (Ka) was amplified from the clon-
ing vector pET28a. The three amplicons (upstream, downstream, and Ka) were ligated in a single microcentri-
fuge tube, using the Gibson Assembly Master Mix. The assembled PCR product was transformed into resistant 
strains by electrotransformation, and resistant colonies were selected on blood agar plates containing 50 μg/mL 
kanamycin.
To further confirm the role of each mutant gene to the resistance phenotype, cje1167 and cje1432 were selected 
to construct the knockin mutant strains using single gene insertion method. Briefly, the cje1167 and cje1432 gene 
were amplified from C4 mutant strains using primers pCje1167-F, pCje1432-F and pCje1167-R, pCje1432-R, 
respectively (Table S5 in the Supplemental Material), respectively and cloned into the pUC19 suicide vector 
(TaKaRa). This suicide vector was then attempted to transfer into C. jejuni ATCC 33560 and C. jejuni NCTC 
11168, respectively by natural transformation. The transformants were selected on MH agar plates containing 
CAP (2 μg/mL). Resistant phenotype was determined to verify the function of the selected mutant genes.
Protein lysis and digestion. Drug susceptibility tests showed that the MICs of C. jejuni parental strain 
and the constructed C4 mutant strains were 4, 256 μg/mL, respectively. The C. jejuni parental strain was cultured 
in blank MH agar, and resistant strains were cultured in MH agar supplemented with 16 μg/mL CAP. Three bio-
logical replicates were performed for each condition. Bacterial cells were harvested and washed with phosphate 
buffered saline twice. Then, a 0.1-g cell pellet was suspended in 1 mL of lysis buffer (7 M urea, 2 M thiourea, 4% 
CHAPS, 65 mM DTT, 1 mM PMSF, and 10 μL nuclease mix) for sonication for 3 min on ice. The sample was cen-
trifuged at 30,000 × g for 30 min (Beckman Coulter Inc., U.S.A.), and the supernatant was subjected to proteomic 
analysis. Additionally, a small aliquot was taken for the Bradford Protein assay (Sangon Biotech, Shanghai). The 
proteins were digested based on filter-aided sample preparation protocol37. Briefly, bovine serum albumin was 
added to 200 μg of protein extract, to a final concentration of 4 pmol. Then, proteins were reduced in 8 M urea 
and 20 mM dithiothreitol buffer at 37 °C for 1 h and alkylated with iodoacetamide (60 mM final concentration) 
in the dark for 30 min. The mixture was then transferred to an ultra-filtration unit (10 kD MWCO, Sartorius) and 
centrifuged at 14,000 × g for 20 min, followed by six rounds of buffer exchange processing with 200 µL of 25 mM 
NH4HCO3 at 14,000 × g for 20 min. Trypsin (4 µg) in 100 µL of 25 mM NH4HCO3 was added to the ultrafiltration 
unit and incubated at 37 °C overnight. Peptides were eluted by centrifuging at 14,000 × g for 20 min, and then 
collected from the collection tube.
Label free quantitative proteomic analysis. For shotgun analysis, samples from both the parental and 
resistant strains were pooled and analysed on TripleTOF® 5600 + (AB SCIEX, Framingham, US), using the data 
independent acquisition (DIA) mode. Peptides were first loaded on a trap column, and then separated on a nano 
column (75 μm × 15 cm, C18, 3 μm) using an Eksigent 415 Nano LC system (AB SCIEX, Framingham, US). The 
flow rate was set to 300 nL/min over a 120-min multi-segment gradient on solvent B (5% dimethyl sulphoxide, 
0.1% formic acid in 93% acetonitrile). Triple technical replicates were conducted with different MS full-scan 
ranges; for the first run, the range was set to 350–1500 m/z; whereas, for the second and third runs, it was set to 
350–750 m/z and 745–1500 m/z, respectively. A top 40 MS/MS acquisition criterion was set, with an accumulation 
time of 75 ms for each spectrum, and the total cycle time was approximately 3.3 s. The MS data were searched 
using ProteinPilot 5.0 to generate the SWATH library, which contained information on targeted proteins, pep-
tides, and their fragment ions for extraction of SWATH data.
For SWATH analysis, the generated library and data files were together loaded into the PeakView v2.2 SWATH 
Processing MicroApp v2.0. Proteins that met the 1% false discovery rate were selected without shared peptides. 
The modified peptides and those with confidence intervals <90% were excluded. Up to 20 peptides were chosen 
per protein. The fragment ions were automatically selected according to the following rules: (i) fragment ions 
of a given peptide were ranked by their intensity; (ii) ions higher in m/z than the y4 fragment ion were ranked 
highest; (iii) ions within the SWATH isolation window were excluded from selection; (iv) if insufficient target ions 
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were found, ions lower than y4 but outside the SWATH window were chosen; (v) if there were still insufficient 
ions, then fragment ions from within the SWATH window region were chosen. Up to six transitions were chosen 
per peptide. Extracted ion chromatograms (XICs) were then generated for the fragment ions of each peptide 
and scored. The XIC extraction time window was set to 15 min, and the mass window was set to 0.05 Da. After 
the peptides were selected for each protein, the retention time was realigned according to 10 manually selected 
peptides that constantly had high signal intensities and were distributed along the entire time axis. The XIC 
areas of the fragment ions of a targeted peptide were summed to represent the peptide. Then, the areas of the 
corresponding peptides were summed to represent the targeted proteins. These areas were then used for relative 
quantification or further statistics analysis.
Statistical analyses. Data normalization was conducted using MarkerView v1.3, based on the total area 
sums algorithm, followed by a t-test analysis. Relative quantitative proteins with p-value <0.01 and fold change 
>2.0 were considered as DEPs. Gene ontology enrichment analysis and functional interaction network of 
up-regulated and down-regulated DEPs were performed by Blast2GO and Cytoscape software.
Targeted proteomic analyses. The SRM experiment was conducted using an Eksigent Nano LC and a 
QTRAP® 6500 MS system (AB SCIEX, Framingham, US). The mobile phase consisted of solvent A (2% ace-
tonitrile and 0.1% formic acid in water) and solvent B (2% water and 0.1% formic acid in acetonitrile). The trap 
column (200 μm × 0.5 mm) and analytical column (75 μm × 150 mm) were packed with 3-μm ChromXP C18-CL 
resin (Eksigent cHiPLC columns). The injection volume was 6 μL. The peptides were separated with a gradient 
from 5% to 20% B over 50 min, to 32% B over 20 min, and to 80% B over 5 min, at a flow rate of 0.3 μL/min. The 
column was then flushed with 80% B for 5 min, and re-equilibrated with 5% B for 10 min. For MS settings, the 
scheduled MRM type was selected with the imported MRM transition list. Other MS parameters were as follows: 
MRM detection window, 600 s; target scan time, 2.5 s; ion source gas 1, 15; curtain gas, 30; ionspray voltage float-
ing, 2400. All the data were acquired using Analyst v1.6 and processed using MultiQuant™ v3.0.
Accession number. Nucleotide sequences for C. jejuni ATCC 33560 genome have been deposited in the 
GenBank WGS database with the accession code PRJNA374478 (accession CP019838).
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